Blancas, Isabel https://orcid.org/0000-0002-5867-6615
Linares-Rodríguez, Marina https://orcid.org/0000-0001-7075-1123
Rodríguez-González, Carlos José https://orcid.org/0000-0002-9004-5362
Rodríguez-Serrano, Fernando https://orcid.org/0000-0002-7105-4060
Funding for this research was provided by:
Consejería de Salud y Familias, Junta de Andalucía (PECART-0207-2020)
Universidad de Granada
Article History
Received: 31 December 2024
Accepted: 13 March 2025
First Online: 11 April 2025
Declarations
:
: Dr. Blancas declares having conflicts of interest that include grants and contracts from the institutions Roche, Agendia, Lilly, Pfizer, and AstraZeneca; consulting fees from AstraZeneca, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Eisai, Gilead, Grünenthal, Jazz Pharmaceutical, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen, and Veracyte; payments or honoraria for lectures, presentations, participation in speaker bureaus, manuscript writing, or educational events from AstraZeneca, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Eisai, Gilead, Grünenthal, GSK, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen, and Veracyte, as well as Medical Scientia Innovation Research (MEDSIR); support for attending meetings and/or travel from AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Gilead, Lilly, Novartis, Pfizer, Pierre-Fabre, and Roche; and participation on Data Safety Monitoring Boards or Advisory Boards for AstraZeneca, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Eisai, Gilead, Grünenthal, GSK, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen and Veracyte.
: Informed, written consent was obtained from all participants involved in the study. Additionally, the research received approval from the Provincial Ethical Committee of Granada, ensuring adherence to ethical standards in the conduct of this research. The study was registered in the European Union Clinical Trials Register (). EudraCT Number: 2007–002942-40. Date on which this record was first entered in the EudraCT database: 2007–09-11.